Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.

Source:http://linkedlifedata.com/resource/pubmed/id/7676498

Transplantation 1995 Sep 15 60 5 481-90

Download in:

View as

Triples

General Info

PMID
7676498